fbpx
October 19, 2021

Updated MS Guidelines Advocate Earlier, More Aggressive Treatment Updated MS Guidelines Advocate Earlier, More Aggressive Treatment

Updated European guidelines on the treatment of patients with multiple sclerosis (MS) have been announced, and include a recommendation for siponimod (Mayzent) in progressive MS, as […]
October 18, 2021

MS and (Non-COVID) Vaccinations: Consensus Recommendations MS and (Non-COVID) Vaccinations: Consensus Recommendations

The first European consensus on vaccination in patients with multiple sclerosis has been developed by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) […]
October 18, 2021

The Barcelona Baseline Risk Score May Predict Long-Term MS Course The Barcelona Baseline Risk Score May Predict Long-Term MS Course

The Barcelona baseline risk score predicted progression of multiple sclerosis (MS) in patients by assigning them to low-, medium-, and high-risk groups. The high-risk group had the […]
October 15, 2021

Rituximab More Effective Than Other MS Treatments? Rituximab More Effective Than Other MS Treatments?

Rituximab reduces relapses and MRI activity in patients with relapsing-remitting multiple sclerosis (MS) more effectively than dimethyl fumarate, natalizumab, and injectable drugs, according to new research. […]
October 15, 2021

ECTRIMS/EAN Statement on COVID-19 Vaccination in MS Patients ECTRIMS/EAN Statement on COVID-19 Vaccination in MS Patients

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and […]
October 15, 2021

Melatonin Improves Sleep in MS Melatonin Improves Sleep in MS

Melatonin improved sleep time and sleep efficiency in patients with multiple sclerosis (MS) who also had sleep disturbance, according to a new pilot study. The study […]
October 15, 2021

Ublituximab Improves Functional MS Score: New ULTIMATE Analysis Ublituximab Improves Functional MS Score: New ULTIMATE Analysis

New data from two phase 3 studies found that in patients with relapsing forms of multiple sclerosis (MS), the new anti-CD20 monoclonal antibody drug, ublituximab, is […]
October 14, 2021

Cortical Lesions Predict Risk for Secondary Progressive MS Cortical Lesions Predict Risk for Secondary Progressive MS

The number of cortical lesions at baseline may indicate a patient’s risk of developing secondary progressive multiple sclerosis (MS), according to new research. Cortical lesions also […]
October 13, 2021

COVID-19 Vax in MS: Lower Response on Certain Medications COVID-19 Vax in MS: Lower Response on Certain Medications

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. New data on COVID vaccination in multiple sclerosis (MS) patients has shown […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0